. Arora, Etiologies, trends, and predictors of 30-day readmission in patients with heart failure. The Am, J. Cardiol, vol.119, pp.760-769, 2017.

M. Fudim, Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HF, Eur. J. Hear. Fail, vol.20, pp.304-314, 2017.

. Ke-joynt and . Jha, Who has higher readmission rates for heart failure, and why?, Circ. Cardiovasc. Qual. Outcomes, vol.4, pp.53-59, 2011.

. As and . Desai, Intensive management to reduce hospitalizations in patients with heart failure, 5. Target: Hf strategies and clinical tools. discharge checklist, vol.133, pp.2019-2026, 2016.

. Mr-cowie, The optimize heart failure care program: Initial lessons from global implementation, Int. J. Cardiol, vol.236, pp.340-344, 2017.

, Discharge checklist of the "groupe insuffisance cardiaque et cardiomyopathies" group of the french society of cardiology, pp.2019-2026

. Mebazaa, Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance, Intensive Care Medicine, vol.42, pp.147-163, 2015.

. Basoor, Decreased readmissions and improved quality of care with the use of an inexpensive checklist in heart failure, Congest. Hear. Fail, vol.19, pp.200-206, 2013.

. Legallois, Improving quality of care in patients with decompensated acute heart failure using a discharge checklist, Arch. Cardiovasc. Dis, 2019.

P. Ponikowski, ESC guidelines for the diagnosis and treatment of acute and chronic heart failure, Eur. Hear. J, vol.37, pp.2129-2200, 2016.

. Gc-fonarow, Day of admission and clinical outcomes for patients hospitalized for heart failure, Circ. Hear. Fail, vol.1, pp.50-57, 2008.

. Gayat, Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity-score matched study, Eur. J. Hear. Fail, vol.20, pp.345-354, 2017.

. Formiga, Basal functional status predicts three-month mortality after a heart failure hospitalization in elderly patients -the prospective RICA study, Int. J. Cardiol, vol.172, pp.127-131, 2014.

K. Cerlinskait-?-e, . Hollinger, . Mebazaa, and . Cinotti, Finding the balance ? between costs and quality in heart failure: a global challenge, Eur. J. Hear. Fail, vol.20, pp.1175-1178, 2018.

C. Opasich, Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure, Eur. Hear. J, vol.26, pp.2232-2237, 2005.

. Cm-porto, . Silva, . Da-luz, and . Filho, VM da Silveira, Association between vitamin d deficiency and heart failure risk in the elderly, ESC Hear. Fail, vol.5, pp.63-74, 2017.

T. Nakamura, Y. Matsumoto, . Haraguchi, . Ishida, and . Ichi-momomura, Prognostic impact of malnutrition assessed using geriatric nutritional risk index in patients aged ?80 years with heart failure

, Eur. J. Cardiovasc. Nurs, p.147451511986497, 2019.

P. Ponikowski, Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency, Eur. Hear. J, vol.36, pp.657-668, 2014.

. Bacchetta, Suppression of iron-regulatory hepcidin by vitamin d, J. Am. Soc. Nephrol, vol.25, pp.564-572, 2013.

M. Wu, Y. Xu, . Wu, and . Lin, Role of vitamin d in patients with heart failure with reduced ejection fraction, Am. J. Cardiovasc. Drugs, 2019.

. K-nolte, Vitamin d deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction, ESC Hear. Fail, vol.6, pp.262-270, 2019.

. Lc-liu, Vitamin d status and outcomes in heart failure patients, Eur. J. Hear. Fail, vol.13, pp.619-625, 2011.

. Zittermann, Effect of vitamin d on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000 IU vitamin d daily, Eur. Hear. J, vol.38, pp.2279-2286, 2017.

. Jd-zhao, Effect of vitamin d on ventricular remodelling in heart failure: a meta-analysis of randomised controlled trials, BMJ Open, vol.8, p.20545, 2018.

. W-chunbin, . Han, and . Lin, Efficacy of vitamin d on chronic heart failure among adults, Int. J. for Vitam. Nutr. Res, pp.1-10, 2019.

. Sd-anker, Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia, Circulation, vol.96, pp.526-534, 1997.

. Eh-bradley, Hospital strategies associated with 30-day readmission rates for patients with heart failure, Circ. Cardiovasc. Qual. Outcomes, vol.6, pp.444-450, 2013.

. Cm-o'connor, Efficacy and safety of exercise training in patients with chronic heart failure, JAMA, vol.301, p.1439, 2009.

, « Par délibération de son Conseil en date du 10 Novembre, 1972.

L. Vu, V. U. Président-de-thèse, . Le-doyen-de-la-faculté, and . Vu,

A. De-soutenance, , 2019.

N. Et and . De-l'auteur,

T. De and L. A. These, Checklist de sortie basée sur un algorithme personnalisé chez les patients admis pour décompensation cardiaque

R. De, L. A. These, and . Français, Introduction. L'utilisation d'une checklist de sortie chez les patients admis pour insuffisance cardiaque (IC) a montré une amélioration de la qualité de vie mais n
URL : https://hal.archives-ouvertes.fr/halshs-00552931

. But, Evaluer l'intérêt d'une checklist de sortie personnalisée (CLP) basée sur des caractéristiques simples (âge, fraction d'éjection ventriculaire gauche (FEVG) et type d'IC) sur la mortalité, les réadmissions pour IC et la qualité de vie

. Méthodes, Une CLP était créée pour chaque patient et remplie avant la sortie. Un groupe contrôle de 182 patients était rétrospectivement inclus l'année précédente. Le critère primaire était la mortalité et les réadmissions à 6 mois pour IC, Nous avons prospectivement inclus 139 patients hospitalisés pour IC entre Mai 2018 et Octobre, 2018.

, Durant les 6 mois de suivi, 32 patients (23%) étaient décédés dans le groupe CLP contre 43 patients (23.2%) dans le groupe contrôle (p=0.94). 38 patients (27.3%) étaient réadmis pour IC dans le groupe CLP contre 64 (35.2%) dans le groupe contrôle avec une divergence des courbes à 2 mois (p=0.12), Résultats. Les cohortes CLP et contrôle étaient comparables sur les caractéristiques de la population comme l'âge moyen et la FEVG

, Conclusion. L'utilisation d'une CLP chez les patients IC ne montre pas de différence sur la mortalité et les réadmissions pour IC. Cependant, une meilleure gestion des comorbidités et un plus grand recours aux programmes de suivis sont observés

, MOTS CLES : insuffisance cardiaque, check-list de sortie, réhospitalisation TITRE DE LA THESE EN ANGLAIS : A personalized algorithm-based discharge checklist in patients with acute heart failure

R. Background, The use of a discharge checklist in patients with acute heart failure (HF) yields a better quality of care, but a single tool may not be suitable in all HF patients. Aims. Evaluate the usefulness of an algorithm-generated personalized discharge checklist (PCL) based on simple baseline characteristics (age, left ventricular ejection fraction (LVEF) and history of HF) on mortality, readmission for HF and quality of care. Methods. We prospectively included 139 patients hospitalized for HF from, 2018.

, During the 6-month follow-up period, 32 patients (23%) died in the PCL cohort vs. 43 patients (23,2%) in the control cohort (p=0.94). 38 patients (27.3%) were hospitalized for HF in the PCL cohort vs. 64 (35.2%) in the control cohort with curves divergence at 2 months (p=0.12). A higher proportion of patients were screened and treated for iron and vitamin D deficiencies as malnutrition supplemented in the PCL group. The post discharge follow-up was better planned in the PCL group were enrolled in a cardiac rehabilitation, telemedicine or PRADO program. Conclusion. There was no difference regarding mortality and HF rehospitalization rate using a PCL in HF patients. However, an improvement in the management of, There was no difference among baseline characteristics between PCL and control cohorts regarding mean age and LVEF

, KEY WORDS : heart failure, discharge checklist, rehospitalisation